Literature DB >> 22049218

A review of the clinical presentation, natural history and inheritance of variegate porphyria: its implausibility as the source of the 'Royal Malady'.

Richard J Hift1, Timothy J Peters, Peter N Meissner.   

Abstract

It has been suggested that King George III of Great Britain suffered from the haem biosynthetic disorder, variegate porphyria. This diagnosis is pervasive throughout the scientific and popular literature, and is often referred to as the 'Royal Malady.' The authors believe it inappropriate to view the case for porphyria purely in terms of symptoms, as has generally been the case in his presumptive acute porphyria diagnosis. Accordingly, this review provides a current description of the natural history and clinical presentation of the porphyrias, against which we measure the case for porphyria in George III and his relatives. The authors have critically assessed the prevalence of porphyria in a population, the expected patterns and frequency of inheritance, its penetrance and its expected natural history in affected individuals, and conclude that neither George nor his relatives had porphyria, based on four principal reasons. First, the rarity of the disease mandates a very low prior probability, and therefore implies a vanishingly low positive predictive value for any diagnostic indicator of low specificity, such as a historical reading of the symptoms. Second, penetrance of this autosomal dominant disorder is approximately 40%, and one may expect to have identified characteristic clinical features of porphyria in a large number of descendants without difficulty. Third, the symptoms of both George III and his relatives are highly atypical for porphyria and are more appropriately explained by other much commoner conditions. Finally, the natural history of the illnesses reported in this family is as atypical for variegate porphyria as are their symptoms.

Entities:  

Mesh:

Year:  2011        PMID: 22049218     DOI: 10.1136/jclinpath-2011-200276

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  5 in total

1.  Paediatric porphyria and human hemin: a treatment challenge in a lower middle income country.

Authors:  Syeda Anum Fatima; Humaira Jurair; Qalab Abbas; Arshalooz Jamila Rehman
Journal:  BMJ Case Rep       Date:  2020-01-08

Review 2.  Psychiatric manifestations of treatable hereditary metabolic disorders in adults.

Authors:  Caroline Demily; Frédéric Sedel
Journal:  Ann Gen Psychiatry       Date:  2014-09-24       Impact factor: 3.455

Review 3.  Psychiatric signs and symptoms in treatable inborn errors of metabolism.

Authors:  S Nia
Journal:  J Neurol       Date:  2014-09       Impact factor: 4.849

Review 4.  A boy with blistering of sun-exposed skin and finger shortening: the first case of Variegate Porphyria with a novel mutation in protoporphyrinogen oxidase (PPOX) gene in Iran: a case report and literature review.

Authors:  Mohammad Vafaee-Shahi; Saeide Ghasemi; Aina Riahi; Zahra Sadr
Journal:  Ital J Pediatr       Date:  2022-02-14       Impact factor: 2.638

5.  A case report on variegate porphyria after etonogestrel placement.

Authors:  Arianna Strome; Spencer D Hawkins; Yuan Yu Huang; Yolanda R Helfrich
Journal:  JAAD Case Rep       Date:  2022-03-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.